Avacta Group Plc (AIM:AVCT)
London · Delayed Price · Currency is GBP · Price in GBX 68.50
+6.50 (10.48%)
At close: Mar 4, 2026
Avacta Group Market Cap
Avacta Group has a market cap or net worth of 299.62 million as of March 5, 2026. Its market cap has increased by 96.02% in one year.
Market Cap
299.62M
Enterprise Value
307.38M
Revenue
113.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
68.50
Market Cap Chart
Since September 29, 2006, Avacta Group's market cap has increased from 37.46M to 299.62M, an increase of 699.85%. That is a compound annual growth rate of 11.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 299.62M | 19.19% |
| Dec 31, 2025 | 251.39M | 37.41% |
| Dec 31, 2024 | 182.95M | -43.88% |
| Dec 29, 2023 | 325.99M | 9.26% |
| Dec 30, 2022 | 298.35M | -5.82% |
| Dec 31, 2021 | 316.78M | 11.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 1.95B |
| Oxford Nanopore Technologies | 1.29B |
| Oxford Biomedica | 801.12M |
| PureTech Health | 296.79M |
| Scancell Holdings | 139.06M |
| 4basebio | 85.13M |
| Bioventix | 80.99M |
| Hemogenyx Pharmaceuticals | 71.16M |